Avivagen Inc VIVXF

Healthcare

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Post by hipfneron Dec 26, 2017 6:49pm

202 Views

Post# 27227840

Interesting technology, failing business model?

It's a compelling solution to a real problem.

But losing approx. $5 milllion annually is not sustainable, as stated in their MD&A. I see that they've raised cash repeatedly and consolidated shares earlier this year. And no CEO...

Why are they making partnerships and sales in the Far East and not in North America and Europe?

I've read through the material on the website and Sedar.

(I've invested in many superior technologies that have gone to zero, so I'm not risk averse.)

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”